These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9093910)
21. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential. Xie S; Kang JX Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733 [TBL] [Abstract][Full Text] [Related]
22. Major influence of cell differentiation status on characteristics of proteoglycans synthesized by cultured rabbit renal proximal tubule cells: role of insulin and dexamethasone. Lelongt B; Vandewalle A; Brenchley PE; Baudouin B; Géniteau-Legendre M; Verroust PJ; Ronco PM J Cell Physiol; 1993 Jan; 154(1):175-91. PubMed ID: 8419403 [TBL] [Abstract][Full Text] [Related]
23. Proteoglycans synthesized by gingival fibroblasts derived from human donors of different ages. Bartold PM; Boyd RR; Page RC J Cell Physiol; 1986 Jan; 126(1):37-46. PubMed ID: 3944197 [TBL] [Abstract][Full Text] [Related]
24. Alterations in epidermal sulfated proteoglycan production following topical application of the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate to mouse skin. Laskin JD; Dokidis A; Laskin DL Cancer Biochem Biophys; 1991 Aug; 12(2):69-79. PubMed ID: 1769011 [TBL] [Abstract][Full Text] [Related]
25. Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231. el Yazidi I; Boilly-Marer Y Anticancer Res; 1995; 15(3):783-90. PubMed ID: 7544091 [TBL] [Abstract][Full Text] [Related]
26. Bone marrow stromal proteoglycan heterogeneity: phenotypic variability between cell lines and the effects of glucocorticoid. Bentley SA; Kirby SL; Anklesaria P; Greenberger JS J Cell Physiol; 1988 Jul; 136(1):182-7. PubMed ID: 3397395 [TBL] [Abstract][Full Text] [Related]
27. Cellular specificity for the activation of fibroblast growth factor-2 by heparan sulfate proteoglycan. Fiore MM Biochem Biophys Res Commun; 2001 Jun; 284(2):384-8. PubMed ID: 11394890 [TBL] [Abstract][Full Text] [Related]
28. Proteoglycan synthesis by normal and neoplastic human transitional epithelial cells. Knudson W; Subbaiah S; Pauli BU J Cell Biochem; 1990 Jul; 43(3):265-79. PubMed ID: 2380265 [TBL] [Abstract][Full Text] [Related]
29. IGF-I affects glycosaminoglycan/proteoglycan synthesis in breast cancer cells through tyrosine kinase-dependent and -independent pathways. Mitropoulou TN; Theocharis AD; Nikitovic D; Karamanos NK; Tzanakakis GN Biochimie; 2004; 86(4-5):251-9. PubMed ID: 15194227 [TBL] [Abstract][Full Text] [Related]
30. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708 [TBL] [Abstract][Full Text] [Related]
31. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing. Kosir MA; Quinn CC; Wang W; Tromp G J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481 [TBL] [Abstract][Full Text] [Related]
32. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells. Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007 [TBL] [Abstract][Full Text] [Related]
33. Differential responsiveness of human breast cancer cells to basic fibroblast growth factor: a cell kinetics study. Delehedde M; Boilly B; Hondermarck H Oncol Res; 1995; 7(7-8):399-405. PubMed ID: 8747603 [TBL] [Abstract][Full Text] [Related]
34. Sorting of heparan sulfate proteoglycan into matrix compartments of prostate adenocarcinoma cells. Kosir MA; Quinn CC J Surg Res; 1995 Jan; 58(1):46-52. PubMed ID: 7830405 [TBL] [Abstract][Full Text] [Related]
35. Growth factors and chemotherapeutic modulation of breast cancer cells. Ciftci K; Su J; Trovitch PB J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904 [TBL] [Abstract][Full Text] [Related]
36. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174 [TBL] [Abstract][Full Text] [Related]
37. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol. Chen AC; Guo X; Derguini F; Gudas LJ Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581 [TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253 [TBL] [Abstract][Full Text] [Related]
39. Human breast cell lines exhibit functional alpha2-adrenoceptors. Vázquez SM; Mladovan AG; Pérez C; Bruzzone A; Baldi A; Lüthy IA Cancer Chemother Pharmacol; 2006 Jul; 58(1):50-61. PubMed ID: 16292538 [TBL] [Abstract][Full Text] [Related]
40. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway. Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]